Dow, Exelixis Sign Research Agreement

The agreement focuses on the development of new tools for gene discovery and validation of novel crop traits. The asset purchase by Dow includes intellectual property and physical assets used for crop trait discovery.

“This asset purchase and collaboration will accelerate our gene discovery and validation efforts as we work to bring revolutionary solutions for our customers. Our past collaborations with Exelixis Plant Sciences have been highly productive, and we look forward to continuing that tradition in our relationship,” said Daniel R. Kittle, Ph.D., vice president of research and development for Dow AgroSciences.